Last reviewed · How we verify

NCT06353399

Guided Bone Regeneration With and Without the Use of Intra-marrow Penetrations

Recruiting now NA Last updated 9 April 2024
What this trial tests

NA trial testing Intra-marrow penetrations in Ridge Augmentation in 24 participants. Currently enrolling.

Timeline
15 June 2023
Primary endpoint
30 June 2024
31 December 2024

Quick facts

Lead sponsorUniversity of Louisville
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment24
Start date15 June 2023
Primary completion30 June 2024
Estimated completion31 December 2024
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Louisville

Who can join

18 and older, any sex, with Ridge Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aims of this study are to compare, after 6 months, the clinical and histologic results of intra-marrow penetrations vs no intra-marrow penetrations when performing guided bone regeneration procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ridge Augmentation

Currently open trials in the same condition.

Other University of Louisville trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06353399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing